A new study found that people taking semaglutide (Ozempic and Wegovy) maintained a lower calorie intake for more than a year ...
Adults with overweight or obesity receiving semaglutide eat significantly fewer calories than those on placebo through week ...
People taking semaglutide for weight loss continued to consume significantly fewer calories after 60 weeks on the medication, ...
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep ...
A 60-week study found semaglutide helped participants maintain lower calorie intake and lose more weight than placebo, ...
The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 availab ...
The first generic weight-loss GLP-1 injection Sevmia was recently approved by Health Canada. Here’s what you need to know.
Novo Nordisk will launch its authorised semaglutide copy in South Africa on 27 July, offering a lower-cost alternative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results